The syntheses o
f two selenium analogues (
10 and
11) o
f the naturally occurring sul
fonium ion,salacinol (
3), are described. Salacinol is one o
f the active principles in the aqueous extracts o
f Salaciareticulata that are traditionally used in Sri Lanka and India
for the treatment o
f diabetes. The syntheticstrategy relies on the nucleophilic attack o
f a 2,3,5-tri-
O-benzyl-1,4-anhydro-4-seleno-
D-arabinitol at theleast hindered carbon o
f benzyl- or benzylidene-protected
D- or
L-erythritol-1,3-cyclic sul
fate. The use o
f1,1,1,3,3,3-hexa
fluoro-2-propanol as a solvent in the coupling reaction proves to be bene
ficial. Enzymeinhibition assays indicate that
10 is a better inhibitor (
Ki = 0.72 mM) o
f glucoamylase than
3, which has a
Ki value o
f 1.7 mM. In contrast,
11 showed no signi
ficant inhibition o
f glucoamylase. Compounds
10 and
11 showed no signi
ficant inhibition o
f barley-
fchars/alpha.gi
f" BORDER=0>-amylase or porcine pancreatic-
fchars/alpha.gi
f" BORDER=0>-amylase.